SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-15-039902
Filing Date
2015-11-06
Accepted
2015-11-06 07:30:56
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 EDGE THERAPEUTICS INC 10-Q 9-30-2015 form10q.htm 10-Q 642934
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 86424
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 11940
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 11992
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5261
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 5161
  Complete submission text file 0001140361-15-039902.txt   4085846

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT edge-20150930.xml EX-101.INS 652405
8 XBRL TAXONOMY EXTENSION SCHEMA edge-20150930.xsd EX-101.SCH 35327
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20150930_cal.xml EX-101.CAL 41083
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20150930_def.xml EX-101.DEF 195707
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20150930_lab.xml EX-101.LAB 568519
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20150930_pre.xml EX-101.PRE 308147
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 151202438
SIC: 2834 Pharmaceutical Preparations